Managing High Lactate Levels in Patients with Acute Kidney Injury
In patients with acute kidney injury (AKI) and elevated lactate levels, bicarbonate should be used instead of lactate as a buffer in dialysate and replacement fluid for renal replacement therapy (RRT), especially in those with circulatory shock, liver failure, or lactic acidemia. 1
Understanding Lactate Elevation in AKI
- Elevated lactate in AKI patients is a significant predictor of mortality, with higher levels associated with worse outcomes 2
- The primary causes of elevated lactate include tissue hypoperfusion, sepsis, shock states, and trauma 3
- In AKI, altered glycolysis and gluconeogenesis significantly disturb lactate metabolic balance, impacting disease severity and prognosis 4
- Hyperlactatemia is particularly concerning in critically ill AKI patients requiring continuous renal replacement therapy (CRRT), with higher lactate levels correlating with increased mortality risk 2
Diagnostic Approach
- Measure serum lactate levels to estimate and monitor tissue perfusion status; levels >2 mmol/L indicate potential tissue hypoperfusion 3
- Perform serial lactate measurements to objectively evaluate response to therapy 3
- Consider base deficit values from arterial blood gas analysis as an indirect estimation of global tissue acidosis 3
- Categorize patients based on lactate levels: low (≤2 mmol/L), moderate (2.1-7.5 mmol/L), and high (≥7.6 mmol/L) to stratify mortality risk 2
Management Strategies
Renal Replacement Therapy Considerations
- Use bicarbonate rather than lactate as a buffer in dialysate and replacement fluid for RRT in all AKI patients (Grade 2C recommendation) 1
- This recommendation is stronger (Grade 1B) for patients with AKI and circulatory shock 1
- For patients with AKI and liver failure and/or lactic acidemia, bicarbonate is also preferred over lactate as a buffer (Grade 2B) 1
- Account for additional calories provided by lactate (3.62 kcal/g) in RRT solutions when calculating total daily energy provision to avoid overfeeding 1
Addressing Underlying Causes
- Identify and treat the underlying cause of elevated lactate, focusing on improving tissue perfusion in shock states 3
- In hypovolemic AKI, administer volume replacement (albumin at 1 g per kg body weight to maximum 100 g/day) to reduce serum creatinine 1
- For patients with significant blood loss, maintain hemoglobin at 8 g/dL while carefully monitoring volume status 1
- Consider medication effects on lactate levels, such as those caused by epinephrine through beta-2-adrenergic stimulation 3
Monitoring and Prognostic Implications
- Monitor lactate clearance time, as it is a significant predictor of survival 3
- Normalization of lactate levels within 24 hours is associated with improved survival 3
- Consider adding serum lactate levels to prognostic models like SOFA and APACHE II scores for better mortality risk prediction in CRRT patients 2
- Be aware that initial lactate concentration may not discriminate between survivors and non-survivors in patients with severe lactic acidosis receiving RRT 5
Special Considerations
- CRRT use might be associated with elevation of longitudinal lactate levels in sepsis-associated AKI patients 6
- Energy excess provided by RRT could be partially avoided by using protocols based on lower citrate concentration solutions, bicarbonate as a buffer, and citrate solutions without glucose 1
- Consider diffusive prolonged intermittent kidney replacement therapy modalities like sustained low-efficiency dialysis (SLED), which allow increased citrate removal 1
- Recent research suggests that reducing lactate levels through pyruvate dehydrogenase activation may attenuate sepsis-induced AKI 7
Pitfalls to Avoid
- Don't ignore elevated lactate in seemingly stable patients, as it may indicate occult tissue hypoperfusion 3
- Avoid using high lactate replacement fluids in AKI patients with elevated lactate levels 1
- Don't overlook the caloric contribution of lactate in RRT solutions, which can provide up to 1300 kcal/day 1
- Be aware that critically ill patients with AKI oxidize fewer carbohydrates and more lipids than expected, which may affect nutritional management 1